News

Top news of the day from across the health care landscape.
Sofosbuvir/velpatasvir is the first direct acting antiviral therapy registered for use against all 6 genotypes of hepatitis C.
Cisplatin and platinum-based chemotherapies cause hearing loss in up to 80% of adults and more than 50% of children.
Unapproved stem cell therapies may cause patient harm with serious and life-threatening diseases.
Top news of the day from across the health care landscape.
A look at last week's top stories in the world of pharmacy.
Infectious disease and HIV specialists may be more willing to prescribe HIV preexposure prophylaxis than primary care providers.

Most Popular

Company Profile >
Contributors >
Industry Guide >
Market News >
Peer Exchange >
Conferences >
Subscribe >
Specialty Times Resources
About Us
Advertise
Careers
Contact Us
Terms & Conditions
Privacy
MJH Associates >
Pharmacy Times
OTCGuide
American Journal of Managed Care
Cure
MD Magazine
ONCLive
Targeted Oncology
Physicians' Education Resource
Pharmacy & Healthcare Communications, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright Specialty Pharmacy Times 2006-2017
Pharmacy & Healthcare Communications, LLC. All Rights Reserved.
 

$vacMongoViewPlus$